Clin Asst Prof Chay Wen Yee

About

Dr Chay Wen Yee is a Senior consultant Medical Oncologist at National Cancer Centre Singapore with an interest in gynaecological cancers and breast cancer. She is also a visiting consultant at the Department of Gynecological Oncology, KK Women and Children’s Hospital as well as a Clinical Assistant Professor, Department of Medicine, Singhealth Duke-NUS Oncology Academic Clinic Programme.

Dr Chay’s research interests lie mainly in gynecological cancers particularly in the identification of

biomarkers in mucinous ovarian cancer. She is involved in various investigator initiated as well as in-dustry sponsored trials, both in the capacity of principal investigator and co-investigator. She is a keen educator and is active in both undergraduate and post graduate teaching, previously as Core Faculty, Senior Residency Programme (Medical Oncology) as well as faculty for Duke-NUS Graduate Medi-cal School and clinical tutor for Yong Loo Lin School of Medicine. Dr Chay has been involved with planning and organization of various patient support group activities as part of her role previously as co-chair, Patient Support Group, National Cancer Centre Singapore.

Education and Training

• Master of Medicine (Internal  Medicine), Singapore National University of Singapore, 2007
• MRCP ( UK) 2007
• MBBS, National University of Singapore 2004

Professional Appointments and Committee Memberships

• Chapter of Medical Oncology, Academy of Medicine Singapore,  Committee Member 2019-  Present
• Gynaecologic Cancer Group Singapore Council Member 2018 - Present
• Singapore Cancer Society Women’s Gynaecological Cancers Committee :  Member  2017 –Present
• Academy of Medicine Singapore Member 2012 - Present
• Singapore Society of Oncology Member 2010-  Present
• Singapore Medical Association Member 2005-  Present

Awards

• SingHealth Best Medical Officer Award 2008 
• FY 2014 Health Manpower Development Plan ( HMDP ) Clinical Fellowship in Comprehensive Gynaecology Oncology, BC Cancer Agency, Vancouver, Canada
  

Publications

1. Chay WY, Ong WS, Tan PH et al . Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res. 2012; (Jan 30;14(1):R19.
2. Chay Wen Yee; Kwok Li Lian; Tiong Wen Ning; et al.Mutational Aberrations Detected in Mucinous Epithelial Ovarian Cancer of Asian Women.International journal of gynecological cancer : official journal of the InternationalGynecological Cancer Society 2018; 28(3):428-436.
3. Hwang Jeff Yi-Fu; Lim Wei-Yen; Tan Chuen Seng; Lim Sheow Lei; Chia John; Chow Khuan
   Yew; Chay Wen Yee. Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012. Asian Pacific journal of cancer prevention : APJCP 2019; 20(12):3563-3569
4. Chay WY, Kumar A, Hoskins PJ, et al. Single-Agent Bevacizumab for the management of refractory malignant effusions in heavily pretreated patients with recurrent high-grade serous cancers of the ovary, fallopian tube or peritoneum: results from a single institution. European Journal of Gynaecological Oncology 2018; 39(6):877-880
5. Chay WY, Chew SH, Ong WS, et al HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer. PLoS One. 2013; NA(Apr 19;8(4):e61565. doi: 10.1371/journal.pone.0061):NA-NA
6. Chay Wen Yee; McCluggage W Glenn; Lee Cheng-Han; et al. Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016; 26(3):431-6